Lumentum Holdings Inc. (LITE)
Live price chart, market sentiment, and community perspectives for Lumentum Holdings Inc. (NASDAQ: LITE).
Live price chart, market sentiment, and community perspectives for Lumentum Holdings Inc. (NASDAQ: LITE).
On our desk, LITE has completely shattered expectations. Q4 revenue printed at $1.01 billion, beating consensus and pulling forward long-term targets by more than a quarter. Non-GAAP gross margins crossed 50% for the first time, a threshold management previously only expected at a $2 billion run rate. With September quarter guidance pointing to an EPS midpoint of $4.20—more than the company earned across all of fiscal 2025—the growth narrative is undeniably robust. We are maintaining an aggressive long bias.
Looking at the supply chain bottlenecks, Lumentum is dealing with severe constraints. CEO Michael Hurlston admitted they are way behind on high-power laser shipments as CPO and NPO demand from major hyperscalers outpaces sector production capacity. They are roughly 30% behind EML demand, and ultra-high-power laser demand is accelerating faster than new manufacturing capacity can be brought online. While this signals massive unmet demand, execution risk around scaling capacity remains a critical variable to monitor.
As a risk manager, I am flagging the extreme customer concentration risks alongside the sheer velocity of the guidance upgrades. The September quarter revenue guide of a $1.25B midpoint and monstrous EPS expectations imply that fiscal 2027 could easily exceed $5 billion in revenue. However, with uncertainty regarding demand visibility beyond FY2028 and fixed opex driving massive optical operating margin expansion, we are implementing strict risk controls and sizing option overlays to hedge against sudden macro pullbacks.
From a quantitative and valuation perspective, the multiple looks high at roughly 42x to 45x forward earnings, but that compresses sharply down to about 21.1x looking out to FY3 as earnings rapidly expand. The component side is driving the bulk of the gains—adding $329 million of the $525.6 million June quarter YoY increase compared to Systems. With a forward PEG sitting near 0.35x, we are analyzing whether operating leverage benefits will diminish or if the stock's momentum can sustain this steep trajectory.
In our bio-analyst and tech-infrastructure review, the structural shift toward NPO and CPO architectures in next-gen AI data centers is the core engine here. Lumentum's dual positioning in both merchant and custom chip opportunities gives them a massive moat as the optical interconnects TAM scales toward $90 billion by 2030. Even if some analysts rate the stock a Hold due to valuation and long-term visibility questions, the immediate operational metrics show a company executing at an elite level.
Explore plasma cleansing, somatic organ swaps, and BCI.